TP53AIP1 and lung carcinoma: Functional studies demonstrated that EV-miR-505–5p delivered to lung cancer cells functions as an oncogene, promoting cell proliferation and inhibiting cell apoptosis via the targeting of tumor protein P53-regulated apoptosis-inducing protein 1.